Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep 4;15(1):279.
doi: 10.1186/s13287-024-03912-z.

Research progress and application prospect of adipose-derived stem cell secretome in diabetes foot ulcers healing

Xiaofen Wan #  1   2 , Xuejun Ni #  1   2 , Yunjia Xie  1 , Lu Chen  1 , Beichen Cai  1   2 , Qian Lin  1 , Ruonan Ke  1 , Tao Huang  1 , Xiuying Shan  3   4 , Biao Wang  5   6
Affiliations
Review

Research progress and application prospect of adipose-derived stem cell secretome in diabetes foot ulcers healing

Xiaofen Wan et al. Stem Cell Res Ther. .

Abstract

Diabetic foot ulcers (DFUs) are chronic wounds and one of the most common complications of diabetes, imposing significant physical and mental burdens on patients due to their poor prognosis and treatment efficacy. Adipose-derived stem cells (ADSCs) have been proven to promote wound healing, with studies increasingly attributing these beneficial effects to their paracrine actions. Consequently, research on ADSC secretome as a novel and promising alternative for DFU treatment has been extensively conducted. This article provides a comprehensive review of the mechanisms underlying refractory DFU wounds, the secretome of ADSCs, and its role in promoting wound healing in diabetes foot ulcers. And the review aims to provide reliable evidence for the clinical application of ADSC secretome in the treatment of refractory DFU wounds.

Keywords: Adipose-derived stem cells; Diabetic foot ulcers; Secretome; Wound healing.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Mechanisms of diabetes foot ulcers (Created with BioRender.com). PKC Protein kinase C, AGE Advanced glycation end product, TNFα Tumor Necrosis Factor-alpha, IL Interleukin, ROS Reactive oxygen specie, EPC Endothelial progenitor cell, EC Endothelial cell, ECM Extracellular matrix
Fig. 2
Fig. 2
Mechanism of ADSC secretome in promoting diabetic foot ulcers (Created with BioRender.com). ADSC Adipose-derived stem cell, EVs Extracellular Vesicles, apoVs Apoptotic Vesicles, MVs Microvesicles, Exos Exosomes, EPC Endothelial progenitor cell, EC Endothelial cell, ECM Extracellular Matrix, T cell T lymphocyte cell, B cell B lymphocyte cell, NK cell Natural Killer cell
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. - PMC - PubMed
    1. Ji L. Current challenges of diabetes and metabolic disorders in China. Diabetes Obes Metab. 2023;25(Suppl 1):3–4. - PubMed
    1. McDermott K, Fang M, Boulton AJM, Selvin E, Hicks CW. Etiology, epidemiology, and disparities in the burden of diabetic foot ulcers. Diabetes Care. 2023;46(1):209–21. - PMC - PubMed
    1. Perez-Favila A, Martinez-Fierro ML, Rodriguez-Lazalde JG, Cid-Baez MA, Zamudio-Osuna MJ, Martinez-Blanco MDR, et al. Current therapeutic strategies in diabetic foot ulcers. Med (Kaunas). 2019;55(11):714. - PMC - PubMed
    1. Oyebode OA, Jere SW, Houreld NN. Current therapeutic modalities for the management of chronic diabetic wounds of the foot. J Diabetes Res. 2023;2023:1359537. - PMC - PubMed

LinkOut - more resources